Literature DB >> 15322701

Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.

Yarí E Marín1, Suzie Chen.   

Abstract

Melanoma is the aberrant proliferation of melanocytes, the cells in the skin responsible for pigment production. In the United States the current lifetime risk of melanoma development is 1 in 57 in males and 1 in 81 in females. In its early stages melanoma can be surgically removed with great success; however, advanced stages of melanoma have a high mortality rate due to the lack of responsiveness to currently available therapies. The development of animal models to be used in the studies of melanoma will provide the means for developing improved and targeted treatments for this disease. This review focuses on the recent report of a mouse melanoma model, TG-3, which has implicated the ectopic expression of the metabotropic glutamate receptor 1 (Grm1), a G protein coupled receptor (GPCR), in melanomagenesis and metastasis. The involvement of other GPCRs in cellular transformation, particularly GPCRs in melanoma biology, and signaling of Grm1 are also discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322701     DOI: 10.1007/s00109-004-0566-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  137 in total

1.  Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors.

Authors:  F Ferraguti; B Baldani-Guerra; M Corsi; S Nakanishi; C Corti
Journal:  Eur J Neurosci       Date:  1999-06       Impact factor: 3.386

Review 2.  No longer a molecular black box--new clues to apoptosis and drug resistance in melanoma.

Authors:  K Satyamoorthy; T Bogenrieder; M Herlyn
Journal:  Trends Mol Med       Date:  2001-05       Impact factor: 11.951

3.  Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP.

Authors:  Y M Lu; Z Jia; C Janus; J T Henderson; R Gerlai; J M Wojtowicz; J C Roder
Journal:  J Neurosci       Date:  1997-07-01       Impact factor: 6.167

4.  Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation.

Authors:  D Julius; T J Livelli; T M Jessell; R Axel
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

5.  Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains.

Authors:  D Young; G Waitches; C Birchmeier; O Fasano; M Wigler
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

Review 6.  Transgenic mouse models for tumors of melanocytes and retinal pigment epithelium.

Authors:  F Beermann; A Hunziker; A Foletti
Journal:  Pigment Cell Res       Date:  1999-04

Review 7.  Structure and function of melanocytes: microscopic morphology and cell biology of mouse melanocytes in the epidermis and hair follicle.

Authors:  T Hirobe
Journal:  Histol Histopathol       Date:  1995-01       Impact factor: 2.303

8.  Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Authors:  Kayo Arikawa; Noriko Takuwa; Hironori Yamaguchi; Naotoshi Sugimoto; Joji Kitayama; Hirokazu Nagawa; Kazuhiko Takehara; Yoh Takuwa
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

9.  Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors.

Authors:  H Daub; F U Weiss; C Wallasch; A Ullrich
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

10.  Mitotic activity of epidermal melanocytes in UV-irradiated mouse skin.

Authors:  I K Rosdahl; G Szabó
Journal:  J Invest Dermatol       Date:  1978-03       Impact factor: 8.551

View more
  15 in total

Review 1.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

Review 3.  Metabotropic glutamate receptors in cancer.

Authors:  Lumeng J Yu; Brian A Wall; Janet Wangari-Talbot; Suzie Chen
Journal:  Neuropharmacology       Date:  2016-02-16       Impact factor: 5.250

4.  Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor.

Authors:  John O DiRaddo; Sergey Pshenichkin; Tara Gelb; Jarda T Wroblewski
Journal:  Gene       Date:  2013-02-24       Impact factor: 3.688

Review 5.  G-protein-coupled receptors and melanoma.

Authors:  Hwa Jin Lee; Brian Wall; Suzie Chen
Journal:  Pigment Cell Melanoma Res       Date:  2008-05-27       Impact factor: 4.693

6.  Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation - possible role as a dependence receptor.

Authors:  Sergey Pshenichkin; Monika Dolińska; Małgorzata Klauzińska; Victoria Luchenko; Ewa Grajkowska; Jarda T Wroblewski
Journal:  Neuropharmacology       Date:  2008-06-27       Impact factor: 5.250

7.  Expression of glutamate receptor subunits in human cancers.

Authors:  Andrzej Stepulak; Hella Luksch; Christine Gebhardt; Ortrud Uckermann; Jenny Marzahn; Marco Sifringer; Wojciech Rzeski; Christian Staufner; Katja S Brocke; Lechoslaw Turski; Chrysanthy Ikonomidou
Journal:  Histochem Cell Biol       Date:  2009-06-14       Impact factor: 4.304

8.  Overexpression of GPR39 contributes to malignant development of human esophageal squamous cell carcinoma.

Authors:  Fajun Xie; Haibo Liu; Ying-Hui Zhu; Yan-Ru Qin; Yongdong Dai; Tingting Zeng; Leilei Chen; Changjun Nie; Hong Tang; Yan Li; Li Fu; Xin-Yuan Guan
Journal:  BMC Cancer       Date:  2011-02-25       Impact factor: 4.430

9.  Role of the nervous system in cancer metastasis.

Authors:  Sha Li; Yanlai Sun; Dongwei Gao
Journal:  Oncol Lett       Date:  2013-01-31       Impact factor: 2.967

10.  Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.

Authors:  J J Martino; B A Wall; E Mastrantoni; B J Wilimczyk; S N La Cava; K Degenhardt; E White; S Chen
Journal:  Oncogene       Date:  2012-10-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.